132 related articles for article (PubMed ID: 15655647)
1. Serum concentrations of soluble ICAM-1 and VCAM-1 in patients with colorectal cancer. Clinical implications.
Giannoulis K; Angouridaki C; Fountzilas G; Papapolychroniadis C; Giannoulis E; Gamvros O
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s65-7. PubMed ID: 15655647
[TBL] [Abstract][Full Text] [Related]
2. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of bcl-2 in patients with colorectal cancer.
Giannoulis K; Fountzilas G; Angouridakis N; Angouridaki C; Giannoulis E; Gamvros O
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s56-8. PubMed ID: 15655644
[TBL] [Abstract][Full Text] [Related]
6. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.
Coskun U; Sancak B; Sen I; Bukan N; Tufan MA; Gülbahar O; Sozen S
Int Immunopharmacol; 2006 Apr; 6(4):672-7. PubMed ID: 16504931
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
[TBL] [Abstract][Full Text] [Related]
9. Effect of specific immunotherapy versus loratadine on serum adhesion molecules.
Ferreira MB; Santos MC; Pregal AL; Alonso E; Santos AS; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Oct; 33(8):319-22. PubMed ID: 11763722
[TBL] [Abstract][Full Text] [Related]
10. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation.
Jublanc C; Beaudeux JL; Aubart F; Raphael M; Chadarevian R; Chapman MJ; Bonnefont-Rousselot D; Bruckert E
Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):817-22. PubMed ID: 20685094
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
13. Endothelial adhesion molecules are associated with inflammation in subjects with HIV disease.
Melendez MM; McNurlan MA; Mynarcik DC; Khan S; Gelato MC
Clin Infect Dis; 2008 Mar; 46(5):775-80. PubMed ID: 18225982
[TBL] [Abstract][Full Text] [Related]
14. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome.
Ursavaş A; Karadağ M; Rodoplu E; Yilmaztepe A; Oral HB; Gözü RO
Respiration; 2007; 74(5):525-32. PubMed ID: 17148932
[TBL] [Abstract][Full Text] [Related]
15. Soluble ICAM-1 and VCAM-1 serum levels in uveitis.
Pereira-Neves L; Palma-Carlos ML; Soares I; Pereira-Santos MC; Ganhao F; Palma-Carlos AG
Allerg Immunol (Paris); 1996 Nov; 28(9):302-6. PubMed ID: 8986245
[TBL] [Abstract][Full Text] [Related]
16. Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria.
Bruno CM; Valenti M; Bertino G; Ardiri A; Bruno F; Cunsolo M; Pulvirenti D; Neri S
Minerva Med; 2008 Feb; 99(1):1-5. PubMed ID: 18299691
[TBL] [Abstract][Full Text] [Related]
17. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer.
Basoglu M; Yildirgan MI; Taysi S; Yilmaz I; Kiziltunc A; Balik AA; Celebi F; Atamanalp SS
J Surg Oncol; 2003 Jul; 83(3):180-4. PubMed ID: 12827689
[TBL] [Abstract][Full Text] [Related]
18. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
19. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]